First human tests: obesity drug safety check in two ethnic groups

This early-stage study tested the safety and how the body processes a single dose of an experimental obesity medication called monlunabant. It involved 73 healthy, normal-weight Japanese and Caucasian men to see if the drug was well-tolerated and to measure its levels in the blood. The goal was to gather basic safety information and understand how the drug behaves in people from different ethnic backgrounds before testing it in people with obesity.